PPIG and acute coronary syndrome: Further PK/PD studies are needed to investigate the impact of these CYP-mediated drug–drug interactions on patients receiving prasugrel treatment and particularly in HIV patients with acute coronary syndrome simultaneously treated by prasugrel and ritonavir.